Farmalex SRL
Farmalex reported total assets of 902,185 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jan 2026).
The score of Farmalex shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -52 % Total assets -14 %
Accounts of the company itself (not consolidated).
The full file covers 12 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmalex's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −28,406 € | ||||
| Equity | 86,161 € | ||||
| Cash | 12,655 € | ||||
| EBITDA | 27,526 € | ||||
| Total assets | 902,185 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 30 Jan 2026
- Year ended 30 Jun 2024filed on 26 Dec 2024
- Year ended 30 Jun 2023filed on 18 Dec 2023
- Year ended 30 Jun 2022filed on 07 Feb 2023
- Year ended 30 Jun 2021filed on 14 Jan 2022
Farmalex's financial analysis
- Solvency9.6%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmalex
Farmalex's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0464.917.139
- VAT number
- BE0464917139
- Peppol
- Registered · 0208:0464917139 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Dec 1998
- Registered office
- 2000 Antwerp
- Latest accounts
- 2025 · filed on 30 Jan 2026
- Activity
- Activities of holding companies (NACE 64210)
Farmalex (SRL) has been based in Antwerp since 1998, active in: activities of holding companies. For 2025, it reports a net loss of 28,406 € and equity of 86,161 €; its revenue is not published. Its solvency stands at 9.6%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Farmalex
Companies in the same business, of comparable size and area, outside its group.
- Elocam Activities of holding companies Sambreville · balance sheet 902,523 €
- Parte ENCO Activities of holding companies Antwerp · balance sheet 902,819 €
- Coopman Invest Activities of holding companies Zonnebeke · balance sheet 900,735 €
- Management A. Meyers Activities of holding companies Landen · balance sheet 900,355 €
- Clément Guillet Assurfinance Activities of holding companies Lessines · balance sheet 900,110 €
- VWI Invest Activities of holding companies Laarne · balance sheet 900,072 €
- BONAMIE Estate Activities of holding companies Beernem · balance sheet 904,722 €
- Lianar Activities of holding companies Deerlijk · balance sheet €1.22m
Frequently asked questions about Farmalex
What is the revenue of Farmalex?
Farmalex files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farmalex?
In Belgium, the VAT number is the company number prefixed with BE: BE0464917139 for Farmalex, if the company is VAT-registered. Its company number (CBE) is 0464.917.139.
Where is the registered office of Farmalex?
According to the CBE register, the registered office of Farmalex is in 2000 Antwerp.
What is the equity of Farmalex?
At the close of the 2025 financial year, the equity of Farmalex amounts to 86,161 €, a solvency of 9.6% of total assets.
Who manages Farmalex?
The register lists 2 active mandates at Farmalex. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmalex
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →